tradingkey.logo
tradingkey.logo

Calidi Biotherapeutics Receives FDA Fast Track Designation For Cld-201 (Supernova), A First-In-Class Stem-Cell Loaded Viral Therapy For The Treatment Of Patients With Soft Tissue Sarcoma

ReutersJul 29, 2025 1:33 PM

- Calidi Biotherapeutics Inc CLDI.A:

  • CALIDI BIOTHERAPEUTICS RECEIVES FDA FAST TRACK DESIGNATION FOR CLD-201 (SUPERNOVA), A FIRST-IN-CLASS STEM-CELL LOADED VIRAL THERAPY FOR THE TREATMENT OF PATIENTS WITH SOFT TISSUE SARCOMA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI